Actively Recruiting

Age: 18Years +
All Genders
NCT06613555

Retinal Microvascularization in OCT-angiography and Systemic Diseases

Led by Centre Hospitalier Universitaire Dijon · Updated on 2024-09-26

5000

Participants Needed

1

Research Sites

1041 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Systemic diseases are inflammatory, chronic illnesses affecting different organs and altering their function. At present, there are few non-invasive methods for predicting their onset and progression. Some chronic diseases can be anticipated earlier thanks to predictive indicators. These indicators could help doctors decide which treatment is best suited to each patient. In particular, the state of microcirculation in the eyes, specifically in the retina, is linked to the progression of certain diseases in the body. Unfortunately, assessing the health of the small blood vessels in the retina is complicated. Most current methods are imprecise, difficult to reproduce and require qualified specialists. However, the use of retinal microcirculation appears to be a promising approach to solving these problems. In fact, the structure of retinal blood vessels can be observed easily, painlessly and without invasive procedures, thanks to fundus photographs or scans providing imaging slices known as optical coherence tomography-angiography (OCT-A). The vascularization of the retina is very often presented as a window giving access to the peripheral vascularization (the vascularization of other organs distant from the eyes). For example, we recently demonstrated a link between retinal vascularization and the risk of heart problems in patients with coronary artery disease. The aim of this study is to gather original information on the evolution of retinal vascularization, using specific markers that may be associated with damage to distant organs. By regularly monitoring these changes over time, the researchers hope to identify early changes that could indicate the development or evolution of these diseases. The main aim of this study is to create a database of images obtained by OCT-Angiography in patients with systemic diseases and in healthy individuals. This will enable us to identify early changes in retinal vascularization that may be associated with these systemic pathologies. With this information, we hope to improve early diagnosis and monitoring of diseases, which could have a positive impact on patients\' health.

CONDITIONS

Official Title

Retinal Microvascularization in OCT-angiography and Systemic Diseases

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients who have given oral, free and informed consent
  • Patients with systemic vascular pathology, high cardiovascular risk, inflammatory vascular pathology, or preeclampsia during pregnancy
  • Patients who have already had an OCT-A examination as part of their routine care (patients group)
  • Patients who have given free, oral and informed consent (healthy control group)
  • Patients with no prior systemic or vascular inflammatory pathology and no high cardiovascular risk (healthy control group)
  • Non-diabetic patients (healthy control group)
  • Pregnant patients with risk-free pregnancies recruited from gynecology department (healthy control group)
  • Adult patients without maculopathy recruited from ophthalmology department (healthy control group)
Not Eligible

You will not qualify if you...

  • Ophthalmological history in both eyes including vascular and degenerative macular pathologies (patients and healthy control groups)
  • Minor patients
  • Patients under legal protection such as guardianship, curatorship, or court order
  • Patients unable to give consent
  • Persons not affiliated to a social security scheme
  • Breast-feeding women
  • Persons with contraindication to Tropicamide
  • OCT-A signal strength less than 7
  • Patients with any pathology studied in the case group (healthy control group)
  • Type 1 or type 2 diabetes (healthy control group)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Chu Dijon Bourogne

Dijon, France, 21000

Actively Recruiting

Loading map...

Research Team

L

Louis ARNOULD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here